See every side of every news story

Browser Extension

Friday, April 4, 2025

US Edition

Subscribe Login

Israel-Hamas Conflict

Natural Disasters

Republican Party

Democratic Party

U.S.-Canada Relations

Neuroendocrine Cancer UK image

News from Neuroendocrine Cancer UK

News Home Page Local News Blindspot Feed International Covid-19

International North America South America Europe Asia Australia Africa

Trending Internationally Liberation Day Tariffs Donald Trump Trade War Baseball

Trending in U.S.Israel-Hamas Conflict Tariffs US Politics Republican Party Donald Trump

Trending in U.K.Israel-Hamas Conflict UK Economy Premier League Soccer Social Media

Trending Topics

Liberation Day Tariffs Donald Trump Trade War Israel-Hamas Conflict

CompanyAbout History Mission Blog Testimonials Group Subscriptions Subscribe Gift Free Trial Careers Affiliates

HelpHelp Center FAQ Contact Us For Educators/Libraries Media Bias Ratings Ownership and Factuality Ratings Referral Code News Sources Topics

ToolsApp Browser Extension Daily Newsletter Blindspot Report Newsletter Burst Your Bubble Newsletter Timelines

Gift Privacy Policy Manage Cookies Terms and Conditions

© 2025 Snapwise Inc

Search Blindspot Local

News from Neuroendocrine Cancer UK

Stay current with all the latest and breaking news from Neuroendocrine Cancer UK. Compare headlines and media bias behind news outlets on stories breaking today.

We’ve discovered 9 headlines written by Neuroendocrine Cancer UK during the past 3 months.

The Ground News media bias check for Neuroendocrine Cancer UK is . Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides.

Neuroendocrine Cancer UK’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Stay current with all the latest and breaking news from Neuroendocrine Cancer UK. Compare headlines and media bias behind news outlets on stories breaking today. We’ve discovered 9 headlines written by Neuroendocrine Cancer UK during the past 3 months.

The Ground News media bias check for Neuroendocrine Cancer UK is . Scores are assigned by aggregating bias scores from Ad Fontes Media, Media Bias/Fact Check, and All Sides. Neuroendocrine Cancer UK’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Neuroendocrine Cancer UK

Where is Neuroendocrine Cancer UK located?Neuroendocrine Cancer UK's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Neuroendocrine Cancer UK News

Cabozantinib gains FDA approval for treating advanced neuroendocrine tumors

Medical · United States

Cabozantinib gains FDA approval for treating advanced neuroendocrine tumors

100% Center coverage: 1 sources

Cabozantinib, an oral tyrosine kinase inhibitor, has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of patients with previously treated advanced neuroendocrine tumors (NETs).See the Story

FDA OKs Cabozantinib for Pancreatic Neuroendocrine Tumors

Medical · United States

FDA OKs Cabozantinib for Pancreatic Neuroendocrine Tumors

Approval was based on findings from the pivotal CABINET trial showing improved PFS and response rates vs placebo. Medscape Medical NewsSee the Story

You've scrolled to the bottom of the feed, there are no more stories.

Can This New AI Technology Solve The Biggest Problem In Rare Cancer Research?

Cancer · Edinburgh

Can This New AI Technology Solve The Biggest Problem In Rare Cancer Research?

Onco-Innovations' subsidiary publishes ECLIPSE study protocol using SynoGraph AI platform to create synthetic patient data, potentially revolutionizing clinical trials for rare cancers.See the Story

Improving cancer pathways: Challenges, Overcoming Barriers and Digital Solutions

Improving cancer pathways: Challenges, Overcoming Barriers and Digital Solutions

A recently published report from Public Policy Projects (PPP) and Civica recommends accelerating the uptake of digital technology integration to improve cancer pathway outcomes. The report, titled “Improving cancer pathways: Challenges, Overcoming Barriers and Digital Solutions” was informed by a round-table discussion held with a multidisciplinary group of experts, including clinical oncologists, cancer alliance representatives, clinical nurse…See the Story

National Cancer Plan England 2025 – Consultation Open

National Cancer Plan England 2025 – Consultation Open

National Cancer Plan England 2025 – Consultation Open Last year, Lord Darzi’s independent investigation into the NHS, found the need to improve cancer diagnosis rates, waits and outcomes. To mark World Cancer Day, on Tuesday 4th February 2025, the Secretary of State for Health and Social Care, Wes Streeting spoke to BBC presenter, Nick Robinson about the Government’s vision for cancer care and the launch of a national consultation. You can…See the Story

NICE user involvement: NICE Prioritisation Board

England · England

NICE user involvement: NICE Prioritisation Board

The National Institute for Health and Care Excellence (NICE) set up the NICE Prioritisation Board to help decide topics for guidance development see more information. NICE are looking for two people to join the board to bring a perspective of patients, people who use services, and carers to selection and routing of topics. Time commitment: Meetings take place every two weeks and last for two hours. Reading the meeting papers in advance can take…See the Story

February 2025 Webinar Recording: 'Translating Terminology within Neuroendocrine Cancer Care'

United Kingdom · United Kingdom

February 2025 Webinar Recording: 'Translating Terminology within Neuroendocrine Cancer Care'

In this educational webinar, recorded in February 2025 and presented by Nikie Jervis, Director of Support Services inc. Education & Policy at Neuroendocrine Cancer UK & NMC registered nurse, the topic of terminology in neuroendocrine cancer care is discussed, including: What do we mean by terminology? Why (and how) is it used? Common prefixes, rootSee the Story

NI Cancer Charities welcome life-saving vote on smoking

Smoking · England

NI Cancer Charities welcome life-saving vote on smoking

Health Minister Mike Nesbitt with representatives from the Northern Ireland Cancer Charities Coalition including Cancer Focus Northern Ireland, Action Cancer, Macmillan, Cancer Research UK and Friends of the Cancer Centre. Images: Brian Thompson Photography The Northern Ireland Cancer Charities Coalition has welcomed the Assembly’s vote, with an overwhelming majority, to progressively raise the age at which young people can buy tobacco products,…See the Story